2.3(top 20%)
impact factor
87(top 100%)
papers
457(top 50%)
citations
11(top 50%)
h-index
2.4(top 20%)
extended IF
90
all documents
556
doc citations
19(top 50%)
g-index

Top Articles

#TitleJournalYearCitations
1Diagnostic biomarkers of Alzheimer’s disease: A state-of-the-art reviewBiomarkers in Neuropsychiatry2019117
2Psychomotor slowing in Schizophrenia: Implications for endophenotype and biomarker developmentBiomarkers in Neuropsychiatry202038
3Inflammatory biomarkers in schizophrenia: Implications for heterogeneity and neurobiologyBiomarkers in Neuropsychiatry201937
4Measures of Retinal Structure and Function as Biomarkers in Neurology and PsychiatryBiomarkers in Neuropsychiatry202032
5Prefrontal cortical alterations of glutamate and GABA neurotransmission in schizophrenia: Insights for rational biomarker developmentBiomarkers in Neuropsychiatry202022
6Neurophysiological biomarkers for schizophrenia therapeuticsBiomarkers in Neuropsychiatry202018
7Abnormal stress responsiveness and suicidal behavior: A risk phenotypeBiomarkers in Neuropsychiatry202016
8Retinal structural alterations in chronic versus first episode schizophrenia spectrum disordersBiomarkers in Neuropsychiatry202015
9Neurocognitive and neurophysiological endophenotypes in schizophrenia: An overviewBiomarkers in Neuropsychiatry202014
10Treatment response biomarkers in anxiety disorders: From neuroimaging to neuronally-derived extracellular vesicles and beyondBiomarkers in Neuropsychiatry202013
11Biomarkers and neurobehavioral diagnosisBiomarkers in Neuropsychiatry202113
12Intrinsic neural activity differences in psychosis biotypes: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) consortiumBiomarkers in Neuropsychiatry201912
13Diagnostic biomarkers in Alzheimer’s diseaseBiomarkers in Neuropsychiatry202112
14Complement component 3 levels in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorderBiomarkers in Neuropsychiatry201910
15Neurocircuitry of treatment in anxiety disordersBiomarkers in Neuropsychiatry202210
16High delta and gamma EEG power in resting state characterise dementia in Parkinson’s patientsBiomarkers in Neuropsychiatry20209
17Translational neurophysiological biomarkers of N-methyl-d-aspartate receptor dysfunction in serine racemase knockout miceBiomarkers in Neuropsychiatry20208
18Hippocampal subfield alterations in schizophrenia: A selective review of structural MRI studiesBiomarkers in Neuropsychiatry20208
19Auditory paired-stimuli responses across the psychosis and bipolar spectrum and their relationship to clinical featuresBiomarkers in Neuropsychiatry20208
20Advancing translational research through the interface of digital phenotyping and neuroimaging: A narrative reviewBiomarkers in Neuropsychiatry20218
21White matter pathology is shared across multiple psychiatric brain disorders: Is abnormal diffusivity a transdiagnostic biomarker for psychopathology?Biomarkers in Neuropsychiatry20207
22Gene expression of methylation cycle and related genes in lymphocytes and brain of patients with schizophrenia and non-psychotic controlsBiomarkers in Neuropsychiatry20217
23The potential of microRNAs as putative biomarkers in major depressive disorder and suicidal behaviorBiomarkers in Neuropsychiatry20217
24What can clozapine’s effect on neural oscillations tell us about its therapeutic effects? A scoping review and synthesisBiomarkers in Neuropsychiatry20227
25Therapeutic implications of the serotonin transporter gene in depressionBiomarkers in Neuropsychiatry20196
26Cortical abnormalities and identification for first-episode schizophrenia via high-resolution magnetic resonance imagingBiomarkers in Neuropsychiatry20206
27Tracking a dysregulated gut-brain axis with biomarkers of the microbiomeBiomarkers in Neuropsychiatry20205
28Antibodies against Group A Streptococcus, dopamine receptors, and ganglioside GM1 cross-react with a variety of food antigens, potentially interfering with biomarkers for PANS and PANDASBiomarkers in Neuropsychiatry20205
29Inter-device reliability of swept source and spectral domain optical coherence tomography and retinal layer differences in schizophreniaBiomarkers in Neuropsychiatry20215
30Anterior-posterior axis of hippocampal subfields across psychoses: A B-SNIP studyBiomarkers in Neuropsychiatry20215
31Remote digital phenotyping in serious mental illness: Focus on negative symptoms, mood symptoms, and self-awarenessBiomarkers in Neuropsychiatry20225
32Differential expression of serum extracellular vesicle microRNAs and analysis of target-gene pathways in major depressive disorderBiomarkers in Neuropsychiatry20225
33Change point analyses in prodromal Alzheimer’s diseaseBiomarkers in Neuropsychiatry20204
34Reduced pituitary volume with relative T1 shortening correlates with behavior in Prader-Willi syndromeBiomarkers in Neuropsychiatry20214
35Latent inhibition and its potential as a biomarker for schizophreniaBiomarkers in Neuropsychiatry20203
36Dysregulation of complement system in neuropsychiatric disorders: A mini reviewBiomarkers in Neuropsychiatry20223
37Fluid biomarkers for the diagnosis of neurodegenerative diseasesBiomarkers in Neuropsychiatry20233
38Biomarkers of Alzheimer’s disease: Past, present and future clinical useBiomarkers in Neuropsychiatry20233
39Analysis of choroidal vessel density in patients with multiple sclerosisBiomarkers in Neuropsychiatry20212
40Serum Neurofilament Light concentrations are not associated with renal function in secondary progressive multiple sclerosisBiomarkers in Neuropsychiatry20212
41Characterization of antipsychotic medications, amino acid signatures, and platelet-activating factor in first-episode psychosisBiomarkers in Neuropsychiatry20212
42Click-evoked auditory brainstem responses (ABRs) are intact in schizophrenia and not sensitive to cognitive trainingBiomarkers in Neuropsychiatry20222
43Association between cholesterol and response to escitalopram and nortriptyline in patients with major depression: Study combining clinical and register-based informationBiomarkers in Neuropsychiatry20222
44Biomarkers of delirium and relation to dementia among the elderly in the intensive care unit: A narrative reviewBiomarkers in Neuropsychiatry20232
45Biomarkers in frontotemporal dementia: Current landscape and future directionsBiomarkers in Neuropsychiatry20232
46A meta-analysis of the relationship between sleep and β-Amyloid biomarkers in Alzheimer’s diseaseBiomarkers in Neuropsychiatry20232
47Cerebrospinal fluid biomarkers for normal pressure hydrocephalusBiomarkers in Neuropsychiatry20232
48Commentary: More research needed on predictive biomarkers related to clozapine treatmentBiomarkers in Neuropsychiatry20191
49Post-traumatic stress disorder: A biopsychosocial case-control study investigating peripheral blood protein biomarkersBiomarkers in Neuropsychiatry20211
50A pilot spectroscopy study of adversity in adolescentsBiomarkers in Neuropsychiatry20211